LifeStance Health Group, Inc. (NASDAQ:LFST) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) have received an average rating of “Moderate Buy” from the eleven research firms that are currently covering the company, Marketbeat reports. Four analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $12.8750.

Several analysts have recently commented on LFST shares. Canaccord Genuity Group raised their price target on LifeStance Health Group from $13.00 to $15.00 and gave the company a “buy” rating in a report on Wednesday, September 9th. KeyCorp boosted their target price on shares of LifeStance Health Group from $11.00 to $13.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. JPMorgan Chase & Co. boosted their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a report on Friday, August 14th. Weiss Ratings upgraded shares of LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 11th. Finally, Wall Street Zen cut shares of LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 5th.

Insider Transactions at LifeStance Health Group

In related news, Director Robert Bessler sold 894,337 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $10.13, for a total value of $9,059,633.81. Following the completion of the transaction, the director directly owned 539,763 shares of the company’s stock, valued at $5,467,799.19. This trade represents a 62.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.62, for a total value of $144,890,858.34. Following the transaction, the insider directly owned 98,101,407 shares of the company’s stock, valued at approximately $1,041,836,942.34. This represents a 12.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 14,671,917 shares of company stock worth $155,493,415. 3.50% of the stock is currently owned by insiders.

Institutional Investors Weigh In On LifeStance Health Group

Institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. acquired a new stake in LifeStance Health Group during the 2nd quarter valued at $389,293,000. Vanguard Group Inc. raised its holdings in shares of LifeStance Health Group by 21.1% in the fourth quarter. Vanguard Group Inc. now owns 17,700,041 shares of the company’s stock worth $124,608,000 after acquiring an additional 3,086,506 shares during the last quarter. Silversmith Partners I GP LLC acquired a new position in shares of LifeStance Health Group in the fourth quarter worth $100,842,000. Dimensional Fund Advisors LP lifted its position in shares of LifeStance Health Group by 16.4% in the first quarter. Dimensional Fund Advisors LP now owns 10,367,680 shares of the company’s stock valued at $66,038,000 after acquiring an additional 1,461,215 shares in the last quarter. Finally, Jennison Associates LLC boosted its stake in shares of LifeStance Health Group by 38.5% during the first quarter. Jennison Associates LLC now owns 10,228,801 shares of the company’s stock valued at $65,157,000 after acquiring an additional 2,843,388 shares during the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

LifeStance Health Group Trading Up 3.2%

NASDAQ LFST opened at $13.38 on Thursday. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $5.11 billion, a P/E ratio of 102.93 and a beta of 1.22. LifeStance Health Group has a 52-week low of $4.77 and a 52-week high of $13.56. The firm has a 50-day moving average price of $11.72 and a 200 day moving average price of $9.05.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The company had revenue of $435.35 million for the quarter, compared to analyst estimates of $414.58 million. During the same quarter in the previous year, the company earned ($0.01) EPS. The firm’s revenue for the quarter was up 26.1% compared to the same quarter last year. Equities research analysts expect that LifeStance Health Group will post 0.16 EPS for the current year.

About LifeStance Health Group

LifeStance Health Group, Inc is a behavioral health care company that provides outpatient mental health services through in-person and virtual appointments. Its platform connects patients with psychiatrists, psychologists, psychiatric nurse practitioners, therapists and other licensed clinicians.

The company offers services that may include psychotherapy, psychiatric evaluations, medication management and treatment for conditions such as anxiety, depression, attention-deficit/hyperactivity disorder and other behavioral health needs.